UCB
Climate Impact & Sustainability Data (2016, 2017, 2020, 2020-01 to 2020-06, 2021-01 to 2021-06, 2023)
Reporting Period: 2016
Environmental Metrics
ESG Focus Areas
- Responsible and ethical business conduct
- Building an agile organization
- Environmental stewardship and sustainability
- Providing access to epilepsy care in resource-poor countries
- Employee engagement
Environmental Achievements
- Overall energy consumption decreased by 25%
- Overall scope-1 and scope-2 CO2 emissions were reduced by 40%
- Water consumption at UCB facilities decreased by 12%
- Waste generated at UCB facilities decreased by 11%
- 97% of waste was recovered
Social Achievements
- Invested €15.9 million in training and development
- Launched several initiatives to improve access to epilepsy care in resource-poor countries
- 87% participation rate in UCB Voices employee engagement survey
- €4.25 million spent in community sponsorships and charitable donations
Governance Achievements
- 89% of colleagues completed Code of Conduct training
- No significant risks related to human rights, anti-corruption, or anti-bribery identified
- Three complaints received for deviation to industry voluntary codes regarding good promotional practices, with appropriate preventative actions identified
Climate Goals & Targets
- Carbon neutral by 2030
Environmental Challenges
- Changes in healthcare systems and increased pressure
- Increasing environmental footprint upstream and downstream of operations
- Data limitations due to new information system implementation and changes in reporting scope
Mitigation Strategies
- Implementing Patient Value Strategy
- Better understanding of environmental footprint across the value chain
- Improved data validation and consolidation processes
Supply Chain Management
Responsible Procurement
- Process for selection and engagement of suppliers, contractors, and agents to ensure adherence to human rights, anti-corruption, anti-bribery, and no child labor policies
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI G4
Third-party Assurance: PricewaterhouseCoopers (PwC)
UN Sustainable Development Goals
- SDG 3: Good Health and Well-being
- SDG 4: Quality Education
- SDG 5: Gender Equality
- SDG 8: Decent Work and Economic Growth
- SDG 9: Industry, Innovation and Infrastructure
- SDG 13: Climate Action
- SDG 17: Partnerships for the Goals
UCB's engagement in various initiatives linked to the SDGs
Awards & Recognition
- London Stock Exchange’s FTSE4Good Index
- ECPI
- Corporate Knights
- First prize of the EFPIA Patient Think Tank
Reporting Period: 2017
Environmental Metrics
ESG Focus Areas
- Environmental
- Social and employee matters
- Human rights
- Anti-corruption and bribery
- Diversity & Inclusion
Environmental Achievements
- Reached more than 92% green electricity (generated from renewable sources)
- Reduced overall energy consumption by 5%
- Reduced overall water consumption by 6%
- Reduced waste generation by 19%
- Recovered 91% of waste
Social Achievements
- Launched or expanded patient support programs (UCB Cares® and UCB Assist)
- 88% of employees consider UCB a socially responsible company
- €7 million spent in community sponsorships and charitable donations
- 19.5 hours of average training per employee
- Improved employee engagement (85% participation rate in UCB Voices survey)
Governance Achievements
- Implemented a company-wide due diligence process to assess human rights risks with new partners and suppliers
- Completed mandatory training programs (Code of Conduct, Patient Safety Reporting, Anti-Bribery and Anti-Corruption)
Climate Goals & Targets
- Reduce GHG emissions by 70% by 2050
- Reduce GHG emissions by 35% by 2030
- Reduce water consumption by 20% by 2030
- Reduce waste generation by 25% by 2030
- Achieve carbon neutrality by 2030 for directly controlled operations
- Not disclosed
Environmental Challenges
- Attracting, retaining, and engaging key leadership profiles and critical expertise in a competitive talent market
- Ensuring adequate awareness of compliance requirements among workforce to mitigate reputational and regulatory risks
- Maintaining a safe and healthy work environment
- Addressing climate change regulatory requirements and their potential impact on compliance and value chain
- Numeric safety imbalance in Evenity™ cardiovascular events
Mitigation Strategies
- Robust annual human resources processes, competitive remuneration, employee performance reviews, continuous learning opportunities, periodic employee engagement surveys, and well-being initiatives
- Specific training programs, systematic process controls of financial transactions, regular monitoring, integrity due diligence, and adherence to high standards by third parties
- Implementation of certified Health & Safety management systems, periodic emergency exercises, regular inspections, and defining minimum global health & safety requirements
- Stringent action plan to make operations carbon neutral by 2030, including reduction and compensation mechanisms
- Comprehensive evaluation underway to understand the safety signal observed in Evenity™
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Strong centralized governance, risk management, and high-quality standards enforced by the Supply Chain Security Council
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Continuously changing regulatory requirements aimed at mitigating climate change
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: GRI G4 Sustainability Reporting Indicators
Certifications: ISO 14001 (Slough, Braine, Bulle, Zhuhai), OHSAS 18001 (Bulle, Slough, Zhuhai)
Third-party Assurance: PricewaterhouseCoopers (PwC)
UN Sustainable Development Goals
- Not disclosed
The SDGs serve as a reference for the company.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- London Stock Exchange's FTSE4Good Index
- ECPI
- Corporate Knights
- EURORDIS Company Award
- Best Ideas Award (UCB Iberia)
- Best Company Award 2017 (UCB China)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Scientific innovation
- Access to medicines
- Employees’ health, safety and wellbeing
- Health of the planet
- Diversity, equity, and inclusion
- Ethical business practices
Environmental Achievements
- Reduced CO2 emissions by 60% compared with 2015 benchmark
- Reduced water withdrawal by 30% compared to 2015 benchmark
- Reduced waste production by 38% compared to 2015 benchmark
- Achieved 95% renewable energy share for electricity
Social Achievements
- Positively impacted over 3.5 million patients' lives in 2020
- Launched UCB Community Health Fund
- Evolved health, safety and wellbeing (HSWB) ambition and delivery model, including the launch of a new HSWB index
- Implemented various wellbeing and support programs for employees during the COVID-19 pandemic
Governance Achievements
- Established a sustainability governance framework comprised of two bodies: Sustainability Governance Committee and External Sustainability Advisory Board
- Completed Code of Conduct training for 8,034 employees (95% completion rate)
- Completed ABAC training for 97% of employees
- Maintained 100% compliance with health and safety of products regulations and voluntary codes
Climate Goals & Targets
- Reduce CO2 emissions and become carbon neutral for the operations we control directly by 2030
- By 2025, lead in specific patient populations (partial onset/focal epileptic seizures, psoriatic arthritis, osteoporosis-related fractures, myasthenia gravis, and sub-populations of women of childbearing age)
- Have 60% of the emissions created by our suppliers covered by SBTi-like targets by 2025
- Reduce water withdrawal by 20% by 2030
- Reduce waste production by 25% by 2030
Environmental Challenges
- Competition from biosimilars, generics and new drug classes
- Intensity of successive product launches
- Exchange rate volatility
- Global pricing and access challenges
- Cybersecurity/big data and artificial intelligence
- Intellectual property
- Impact of COVID-19 pandemic
Mitigation Strategies
- Investing in superior overall value propositions in target patient populations; diversifying portfolio
- Matching capabilities and reallocating resources and talents in an agile way
- Hedging anticipated foreign currency cash flows
- Actively engaging in collaboration with payor and industry associations
- Multifaceted cybersecurity and data management strategy
- Proactively aware of the competitive landscape around our programs; actively defending key patents
- Implementing safety measures & wellbeing programs; continued supply of medicines; financial assistance for patients; contribution to COVID-19 research
Supply Chain Management
Supplier Audits: 100 suppliers assessed on sustainability performance (2020)
Responsible Procurement
- Suppliers Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Climate change, regulatory requirements, transition to low carbon economy
Opportunities
- Development of energy-efficient products
Reporting Standards
Frameworks Used: GRI Standards
Certifications: ISO 14001, OHSAS 18001
Third-party Assurance: Third-party assurance provider (unspecified)
UN Sustainable Development Goals
- SDG 3 (Good Health and Well-being)
- SDG 13 (Climate Action)
- SDG 17 (Partnerships for the Goals)
The report details how UCB's initiatives contribute to these goals.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- European Carton Excellence Gold Award
Reporting Period: 2020-01 to 2020-06
Environmental Metrics
Social Achievements
- Ensuring employee safety and financial support during the COVID-19 pandemic.
- Providing targeted financial support and in-kind donations to local communities.
- Giving extended payment terms to some vendors.
Climate Goals & Targets
Environmental Challenges
- Impact of the COVID-19 pandemic on clinical studies (pause in new patient recruitment and postponement of new study starts).
Mitigation Strategies
- Restarted clinical study recruitment and new study starts at sites meeting restart criteria.
- Closely monitoring the impact of COVID-19 on ongoing clinical trials and implementing necessary changes.
- Not applying for public support measures.
- Not planning renegotiation of major contracts.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: IAS 34
Reporting Period: 2021-01 to 2021-06
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Impact of COVID-19 pandemic on staff, patients, partners, and communities.
Mitigation Strategies
- Prioritizing assistance to employees, patients, and communities; implementing measures to protect health and ensure business critical activities; monitoring the impact of COVID-19 on clinical trials and implementing changes as necessary; leveraging multi-sourcing for key materials in its global supply chain to mitigate the impact of supply disruptions.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: IFRS
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Human Rights
- Sustainability
- Ethical Business Conduct
Social Achievements
- Commitment to creating a diverse, equitable and inclusive work environment for employees.
- Commitment to fair practices and safe working conditions.
- Respect for employee rights (unionization, living wage, reasonable working hours).
Governance Achievements
- Establishment of a Human Rights Policy defining commitments, roles, responsibilities, and guiding principles.
- Implementation of a grievance mechanism for reporting complaints and addressing adverse human rights impacts.
- Strict non-retaliation policy to protect employees raising concerns or reporting misconduct.
Climate Goals & Targets
- By 2030, all people who need our medicines in countries where we operate have access to them in a manner that is viable for patients, society, and UCB.
Environmental Challenges
- Potential adverse human rights impacts in all parts of the business and supply chain.
Mitigation Strategies
- Commitment to mitigating negative impacts and addressing potential adverse impacts.
- Compliance with applicable laws and internationally recognized human rights principles.
- Due diligence processes to identify and address priority human rights issues.
- Supplier Code of Conduct to drive environmental sustainability and respect for human rights.
Supply Chain Management
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: UN Global Compact, UN Guiding Principles on Business and Human Rights